Skip to main content

Table 2 Oral manifestations and mortality during the follow-up period

From: The effect of pilocarpine on dental caries in patients with primary Sjögren’s syndrome: a database prospective cohort study

Variable

Pilocarpine (n = 1014)

Non-user (n = 2028)

p

First dental caries visit

 Event number, n (%)

487 (48.0)

1047 (51.6)

 

 Incidence density (95% CI)§

27.4 (25.0–29.9)

30.5 (28.7–32.4)

 

 Hazard ratio (95% CI)

0.93 (0.82, 1.06)

Reference

0.283

Annual number of dentist visiting for dental caries

 Annual number (mean ± SD)

0.70 ± 1.11

0.75 ± 1.18

 

 Rate ratio (95% CI)

0.95 (0.85, 1.07)

Reference

0.433

First periodontitis visit

 Event number, n (%)

599 (59.1)

1248 (61.5)

 

 Incidence density (95% CI)§

39.1 (35.9–42.2)

41.8 (39.5–44.1)

 

 Hazard ratio (95% CI)

0.91 (0.81, 1.03)

Reference

0.124

Annual number of dentist visiting for periodontitis

 Annual number (mean ± SD)

0.78 ± 1.06

0.80 ± 1.07

 

 Rate ratio (95% CI)

1.004 (0.90, 1.11)

Reference

0.942

First oral candidiasis

 Event number, n (%)

27 (2.7)

48 (2.4)

 

 Incidence density (95% CI)§

1.02 (0.64–1.40)

0.91 (0.65–1.17)

 

 Hazard ratio (95% CI)

1.16 (0.70, 1.94)

Reference

0.565

  1. CI confidence interval, SD standard deviation;
  2. §Incidence density: number of events per 100 person-years